About Careers MedBlog Contact us

New Anti-inflammatory Substances Discovered

by Anjali Aryamvally on May 4, 2018 at 11:09 AM
Font : A-A+

New Anti-inflammatory Substances Discovered

A new family of substances has been discovered which could inhibit inflammation. These anti-inflammatory substances were found to display highly potent activity against the release of pro-inflammatory cytokines and the toxicity induced by ROS. The study is published in the Journal of Medicinal Chemistry. Inflammation , and in particular chronic inflammation, are major contributors to a large number of diseases, such as cancer, acute pancreatic inflammation, fatty liver disease, diabetes, ulcerative colitis, Crohn's disease, rheumatoid arthritis, chronic liver disease, atherosclerosis, multiple sclerosis, and many others. These pathological conditions are associated with the release of substances, known as pro-inflammatory cytokines, by the immune system. These substances participate in the neutralization of invading pathogens, repair injured tissues, and promote wound healing. However, during chronic or excessive activation of the immune system, when these cytokines are released in an uncontrolled manner, they can lead to unnecessary inflammation that frequently causes tissue damage.


In addition, a family of substances, designated as reactive oxygen species (ROS) is also among the major contributors to many chronic diseases. ROS are involved in oxidation processes. Although oxidative reactions catalyzed by ROS are of great importance in metabolic processes and removal of toxic substances from the body, they are also involved in major damage to cells and tissues leading to cell death, possible DNA mutations and aging. Though the presence of oxygen is necessary for maintaining life, oxygen and its derived products (ROS) are involved in a variety of toxic effects. It has been said that "without oxygen we die but oxygen kills us".

The novel compounds synthesized and evaluated belong to a family of low molecular weight substances named indolines. In early experiments, these compounds have shown promising activity in the treatment of acute pancreatic inflammation, acute fatty liver damage, and diabetes.

"It is expected that further studies in humans will reveal the potential usefulness of these substances in the treatment of a variety of diseases where inflammation is a major contributor to the disease," says Prof. Nudelman, a lead author of the paper. Further studies on the influence of these compounds on these diseases, and other pathological conditions, are being conducted.

Source: Eurekalert


Latest Research News

 New Insights into How the Immune System Responds to Spinal-Cord Injuries
New study findings delineate how aging affects the immune response following Spinal cord injury (SCI) and highlight the participation of the spinal cord meninges in repair.
Nearsightedness: Atropine Eye Drops may Slow Progression in Kids
A recent clinical trial suggests that the first medication therapy to reduce the progression of nearsightedness in children could be on the way.
Autoimmune Diseases Affect One in Ten: Study
Autoimmune disorders were found to be linked to Sjogren's, systemic lupus erythematosus, and systemic sclerosis.
Remarkable Journey of Transforming Lives With Brain Pacemaker
Successful brain pacemaker implantation has helped a 51year old Parkinson's disease patient to revitalize her quality of life.
What Are the Effects of Healthy Lifestyle on Osteoarthritis?
Recent recommendations on lifestyle behaviors to prevent progression of rheumatic and musculoskeletal diseases revealed.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

New Anti-inflammatory Substances Discovered Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests